AUGMENT 102; AUGMENT-102; azacitidine; Beat AML; chemo; chemotherapy; combination; combo; cytarabine; decitabine; EVOLVE-2; FLA; fludarabine; front line; newly diagnosed; relapsed; SAVE; venetoclax; REVEAL-ND; REVEAL; gilteritinib